Timothy Rolph Akero Therapeutics, Inc. (AKRO) insider trading activity
Timothy Rolph is Chief Scientific Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 169,721 shares of AKRO, which is worth approximately $7.25 Million. The most recent transaction as insider was on Dec 29, 2022, when has been sold 20,316 shares (Common Stock) at a price of $50.97 per share, resulting in proceeds of $1,035,506. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
170K
7.88%
3M change
7.03%
12M change
Total Value Held
$7.25 Million
Timothy Rolph Transaction History
TR
Timothy Rolph
Chief Scientific Officer
South San Francisco, CA